First choice for refractory OAB: botulinum toxin A or sacral neuromodulation?
- Authors
- Findlay MacAskill and Arun Sahai
- Peer Reviewer
- Sohier Elneil
- Date of Publication
- November 2023
- DOI
- https://doi.org/10.18591/BJUIK.0055.v2
This is an update of the original module published in Oct 2016.
Previous version: https://doi.org/10.18591/BJUIK.0055
